Puylaert Kevin sold SOPH
March 19, 2026 · Form 4 insider transaction
Puylaert Kevin sold 33 shares of SOPHiA GENETICS SA at $4.76 per share, a transaction worth $157.08. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
33
Price
$4.76
Total value
$157.08
InsiderPuylaert Kevin
Role—
CompanySOPHiA GENETICS SA (SOPH)
SecurityOrdinary Shares
Transaction codeS: Open-market sale
Transaction dateMarch 19, 2026
Filing dateMarch 20, 2026
Shares owned after92,386
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares sold by the Reporting Person in the open market to satisfy tax obligations in connection with the vesting of restricted stock units on March 18, 2026. The sales were effected as a "sell to cover" transaction and do not represent discretionary trades.